User profiles for Anne-Marie Mes-Masson

Anne-Marie Mes-Masson

Professor, Departement of Medicine, Université de Montréal
Verified email at umontreal.ca
Cited by 49940

[HTML][HTML] ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas

…, SA Aparicio, IM Shih, AM Mes-Masson… - … England Journal of …, 2010 - Mass Medical Soc
Background Ovarian clear-cell and endometrioid carcinomas may arise from endometriosis,
but the molecular events involved in this transformation have not been described. Methods …

The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr/abl Hybrid Gene

Y Ben-Neriah, GQ Daley, AM Mes-Masson, ON Witte… - Science, 1986 - science.org
Chronic myelogenous leukemia (CML) is a human disease associated with a consistent
chromosomal translocation that results in sequences from the c-abl locus on chromosome 9 …

[HTML][HTML] Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary

…, DDL Bowtell, AM Mes-Masson… - … England Journal of …, 2009 - Mass Medical Soc
Background Granulosa-cell tumors (GCTs) are the most common type of malignant ovarian
sex cord–stromal tumor (SCST). The pathogenesis of these tumors is unknown. Moreover, …

Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma

…, N Rosenfeld, AM Mes Masson… - The Journal of …, 2016 - Wiley Online Library
TP53 mutations are ubiquitous in high‐grade serous ovarian carcinomas (HGSOC), and the
presence of TP53 mutation discriminates between high and low‐grade serous carcinomas …

Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients

…, N Delvoye, R Lapointe, AM Mes-Masson… - Journal of …, 2009 - Elsevier
INTRODUCTION: Our goal was to study the hormonal regulation of immune cell infiltration in
prostate cancer patients treated by androgen deprivation therapy (ADT) using an optimized …

Spatially mapping the immune landscape of melanoma using imaging mass cytometry

…, R Jamal, R Lapointe, AM Mes-Masson… - Science …, 2022 - science.org
Melanoma is an immunogenic cancer with a high response rate to immune checkpoint
inhibitors (ICIs). It harbors a high mutation burden compared with other cancers and, as a result, …

Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC)

…, DM Provencher, AM MesMasson - … in cooperation with …, 2007 - Wiley Online Library
Epithelial ovarian cancer (EOC) cell lines are useful tools for the molecular and biological
characterization of ovarian cancer. The use of an in vitro multidimensional (3‐D) culture model …

Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes

…, R Moore, MA Marra, CB Gilks, AM Mes-Masson… - Nature …, 2017 - nature.com
We studied the whole-genome point mutation and structural variation patterns of 133 tumors
(59 high-grade serous (HGSC), 35 clear cell (CCOC), 29 endometrioid (ENOC), and 10 …

Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation

…, S Meloche, F Saad, AM Mes-Masson… - Genes & …, 2013 - genesdev.cshlp.org
Constitutive activation of growth factor signaling pathways paradoxically triggers a cell cycle
arrest known as cellular senescence. In primary cells expressing oncogenic ras, this …

CD73 is associated with poor prognosis in high-grade serous ovarian cancer

…, K Rahimi, C Le Page, D Provencher, AM Mes-Masson… - Cancer research, 2015 - AACR
… Ovarian cancer cell lines were obtained from the laboratory of Anne-Marie Mes-Masson and
were cultured in OSE medium (Wisent) with the addition of 10% bovine serum (FBS; Wisent)…